Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly

Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey

(2015) C. Schofl et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Quality of Life in Acromegaly

(2015) Susan M. Webb et al.   NEUROENDOCRINOLOGY

Reference Intervals for Insulin-like Growth Factor-1 (IGF-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations

(2014) Martin Bidlingmaier et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update

(2013) Laurence Katznelson et al.   Endocrine Practice

Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry

(2013) Roberto Salvatori et al.   Pituitary

Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays

(2011) D. R. Clemmons et al.   CLINICAL CHEMISTRY

Affected Illness Perceptions and the Association with Impaired Quality of Life in Patients with Long-Term Remission of Acromegaly

(2011) Jitske Tiemensma et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A review for clinical outcomes research: hypothesis generation, data strategy, and hypothesis-driven statistical analysis

(2011) David C. Chang et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly

(2009) Roberto Salvatori et al.   Pituitary

Mortality in Acromegaly: A Metaanalysis

(2007) O. M. Dekkers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM